Clinical Challenge of Two Competing Targetable Mutations in Non-Small-Cell Lung Cancer: A Case Report

The development of therapeutic agents targeting products of epidermal growth factor receptor (EGFR) gene mutation and anaplastic lymphoma kinase (ALK) rearrangements has improved survival in patients with non-small-cell lung cancer. EGFR and ALK mutations are generally regarded as mutually exclusive...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sonya Youngju, Yoon, Hyukjin, Han, Eun Ji, Yoo, Ie Ryung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Interesting Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572277/
https://www.ncbi.nlm.nih.gov/pubmed/37835855
http://dx.doi.org/10.3390/diagnostics13193112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572277/
https://www.ncbi.nlm.nih.gov/pubmed/37835855
http://dx.doi.org/10.3390/diagnostics13193112

Ejemplares similares